Carlos
González Juanatey
Universidad de Cantabria
Santander, EspañaPublicaciones en colaboración con investigadores/as de Universidad de Cantabria (144)
2024
-
Combined use of QRISK3 and SCORE2 increases identification of ankylosing spondylitis patients at high cardiovascular risk: Results from the CARMA Project cohort after 7.5 years of follow-up
Seminars in Arthritis and Rheumatism, Vol. 66
-
Use of risk chart algorithms for the identification of psoriatic arthritis patients at high risk for cardiovascular disease: findings derived from the project CARMA cohort after a 7.5-year follow-up period
RMD open, Vol. 10, Núm. 2
2021
-
Cardiovascular mortality and cardiovascular event rates in patients with inflammatory rheumatic diseases in the CARdiovascular in rheuMAtology (CARMA) prospective study-results at 5 years of follow-up
Rheumatology (Oxford, England), Vol. 60, Núm. 6, pp. 2906-2915
2020
-
Impact of Comorbidity on Physical Function in Patients With Ankylosing Spondylitis and Psoriatic Arthritis Attending Rheumatology Clinics: Results From a Cross-Sectional Study
Arthritis Care and Research, Vol. 72, Núm. 6, pp. 822-828
-
Points to consider in cardiovascular disease risk management among patients with rheumatoid arthritis living in South Africa, an unequal middle income country
BMC Rheumatology, Vol. 4, Núm. 1
2019
-
Hyperlipoproteinaemia(a) in patients with spondyloarthritis: results of the Cardiovascular in Rheumatology (CARMA) project
Clinical and experimental rheumatology, Vol. 37, Núm. 5, pp. 774-782
2018
-
Cardiovascular risk stratification in axial spondyloarthritis: Carotid ultrasound is more sensitive than coronary artery calcification score to detect high-cardiovascular risk axial spondyloarthritis patients
Clinical and Experimental Rheumatology, Vol. 36, Núm. 1, pp. 73-80
-
Inflammatory arthritis and heart disease
Current Pharmaceutical Design, Vol. 24, Núm. 3, pp. 262-280
2017
-
Inflammation: NSAIDs and cardiovascular risk in arthritis
Nature Reviews Cardiology
-
Influence of coronary artery disease and subclinical atherosclerosis related polymorphisms on the risk of atherosclerosis in rheumatoid arthritis
Scientific Reports, Vol. 7
-
Lipoprotein(a) concentrations in rheumatoid arthritis on biologic therapy: Results from the CARdiovascular in rheuMAtology study project
Journal of Clinical Lipidology, Vol. 11, Núm. 3, pp. 749-756.e3
2016
-
Cardiovascular risk assessment in patients with rheumatoid arthritis: The relevance of clinical, genetic and serological markers
Autoimmunity Reviews, Vol. 15, Núm. 11, pp. 1013-1030
-
Cardiovascular risk factor assessment: Still an unmet need in chronic inflammatory diseases
Heart, Vol. 102, Núm. 24, pp. 1937-1939
-
Carotid ultrasound in the cardiovascular risk stratification of patients with ankylosing spondylitis: Results of a population-based study
Clinical and Experimental Rheumatology, Vol. 34, Núm. 5, pp. 885-892
-
Influence of elevated-CRP level-related polymorphisms in non-rheumatic Caucasians on the risk of subclinical atherosclerosis and cardiovascular disease in rheumatoid arthritis
Scientific Reports, Vol. 6
-
Subclinical atherosclerosis is not increased in patients with non-radiographic axial spondyloarthritis
Clinical and Experimental Rheumatology
-
The framingham score and the systematic coronary risk evaluation at low cutoff values are useful surrogate markers of high-risk subclinical atherosclerosis in patients with rheumatoid arthritis
Journal of Rheumatology, Vol. 43, Núm. 3, pp. 486-494
-
Vitamin D receptor GATG haplotype association with atherosclerotic disease in patients with rheumatoid arthritis
Atherosclerosis, Vol. 245, pp. 139-142
-
Why is Rheumatoid Arthritis Mortality Still High Despite the Advent of New Therapies? Comment on the Article by Widdifield et al
Arthritis Care and Research
2015
-
Anti-TNF-α therapy reduces endothelial cell activation in non-diabetic ankylosing spondylitis patients
Rheumatology International, Vol. 35, Núm. 12, pp. 2069-2078